drugset / Trial / NCT05669885

Hypersensitivity to Phosphodiesterase 5 Inhibition in Post-Traumatic Headache

NCT05669885

Unknown 21 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindBasic science

Summary

To investigate whether sildenafil (phosphodiesterase 5 inhibitor) induces migraine-like headache in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

Timeline

Start
2023-01-02
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 100 mg Oral